Webinars
ABCs of ERG
In this webinar, Drs. Nate Lighthizer and Mike Cymbor explore the integration of ERG into optometric care for diabetic retinopathy, emphasizing the importance of assessing both retinal structure and function. They discuss advancements in ERG technology, its economic benefits, and its role in clinical decision-making. Through case studies, they demonstrate how functional testing enhances diagnostic confidence and improves patient outcomes.
upcoming webinar
High-Risk, Revealed: ERG in the Exam Lane
Wednesday, April 15th · 8:00 PM Eastern (5:00 PM Pacific)
Have you ever had a patient who surprised you by progressing faster than you expected? Structural testing provides critical insights, but assessing patients’ risk without objective, functional data can feel like reading a map with missing pages. Many eyecare providers are turning to ERG to help fill those gaps. Want to know why?
We invite you to join us for this introductory webinar and peer-to-peer conversation led by Nate Lighthizer, OD, FAAO, and Bradley Grant, OD.
Ophthalmic and Optometric Education
Ready for RETeval
Optometrists Nate Lighthizer and Bradley Grant share how they use the RETeval handheld ERG to make confident, data-driven decisions in patient care – and how functional testing is reshaping early detection and disease management.
ERG in Action
In this webinar, optometrists Nate Lighthizer, OD, FAAO, and Bradley Grant, OD, explore how the RETeval ERG’s objective, functional data is transforming patient outcomes in their own practices. From the latest guidelines for diabetic retinopathy to real patient cases, this webinar shows how the integration of ERG is changing the game in early detection and disease management.
Blueprint for Functional Assessments
In this introductory webinar and peer-to-peer discussion, Drs. Lighthizer and Grant explore the management of complex ocular conditions such as diabetic retinopathy, optic nerve disorders, and other retinopathies using the RETeval handheld ERG, emphasizing how its objective functional data can significantly improve patient outcomes.
Predicting Vision Loss in a Busy Retina Practice
Join Dr. Pamela Weber as she shares how she uses the RETeval to predict vision loss and improve patient outcomes in her busy retina practice. This webinar highlights how the device simplifies ERG testing and effectively detects early retinal dysfunction in conditions like diabetic retinopathy and glaucoma.
Objective Functional Testing for Glaucoma? Yes!
Testing for glaucoma can be tricky, as perimetry is subjective and imaging can be inconclusive. Dr. Justin Schweitzer highlights how ERG provides objective insights into retinal ganglion cell function, helping to identify patients who need closer monitoring, especially when traditional tests yield ambiguous results.
“When Do I Refer out?” Best Management Practices for Diabetic Retinopathy
In this webinar, Dr. Steven Ferrucci emphasizes functional testing with the RETeval device to detect retinal dysfunction before structural changes occur. He highlights the predictive value of the DR score in guiding timely interventions and underscores the importance of integrating functional testing with imaging for personalized, proactive diabetic retinopathy care.
How the RETeval Became a Daily Tool in my Diagnostic Arsenal
Watch as Dr. Cymbor highlights the transformative role of the RETeval in early detection and management of ocular diseases like glaucoma and diabetic retinopathy. Through real-world case studies, he demonstrated how objective, functional testing with this device can uncover retinal issues missed by structural exams, leading to earlier, more effective interventions.
Ask the ERG Experts at AAO — New Orleans 2021
Dr. Khalatbari shares how portable ERG has transformed his ophthalmology practice by providing quick, objective assessments of retinal function for conditions like diabetic retinopathy and glaucoma. He highlights the technology’s ease of integration, clinical impact on patient management, and its role in closing the innovation gap in ophthalmology.
Why (and How) I Adopted Handheld ERG Testing with RETeval
Dr. Justin Schweitzer shares how he uses the handheld RETeval device to enhance his diagnostic precision and improve patient management for glaucoma and diabetic retinopathy. He walks through the value of ERG in detecting retinal dysfunction early, guiding risk assessment, and optimizing clinical workflows.
Detecting Retinal Damage Before It Occurs
Dr. Ernesto Collazo discusses how the RETeval is an innovative tool that enables early detection of retinal damage through quick, non-invasive testing. It allows for proactive diagnosis of conditions like diabetic retinopathy and glaucoma, improving patient outcomes by detecting dysfunction before permanent damage occurs.
Optimizing Patient Outcomes with the RETeval
In this webinar, Dr. Mike Cymbor highlighted the RETeval’s role in early detection and management of glaucoma and diabetic retinopathy. He emphasized the need for advanced diagnostic tools to address the growing demand for eye care professionals and how ERG assessments can enhance disease monitoring and treatment decisions.
Women in Visual Electrophysiology
This electrifying webinar series celebrates groundbreaking advances in visual electrophysiology by four exceptional women researchers from around the globe. From Alzheimer’s and dementia to optic neuropathies and inherited retinal diseases, this series offers a unique opportunity to learn from the leading experts shaping the future of eye health.
Non-Sedated Pediatric ERG Testing
In this webinar, Dr. Victor Pagano discusses the RETeval device and its impact on improving diagnostic accuracy and patient comfort in pediatric ophthalmology by eliminating the need for sedation. He emphasizes its role in enhancing early diagnosis and treatment in children, particularly in challenging cases like dense cataracts or uncooperative young patients.
Webinars in Spanish
Cómo Detectar daños de Retina Antes que Ocurran con el Sistema RETeval, con el Dr. Ernesto Collazo
En este seminario web, el Dr. Collazo explora cómo optimiza los resultados de los pacientes con el dispositivo RETeval. Las pruebas de ERG son uno de los primeros indicadores de enfermedades oculares, como glaucoma y retinopatía diabética, antes de que aparezca el daño en las imágenes estructurales. Con el RETeval, las pruebas son rápidas, eficaces y fáciles de interpretar, sin necesidad de electrodos corneales.
ERG pediátrico sin sedación usando RETeval
En este seminario web, el Dr. Mariano Zanolin presenta la electroretinografía sin sedación en niños, utilizando el dispositivo portátil RETeval con electrodos en la piel. Explica cómo esta tecnología mejora los diagnósticos de trastornos retinianos y facilita la integración en la práctica clínica, reduciendo el estrés y mejorando la experiencia del paciente.